PubMed

Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy.

DeSimone JA, Pomerantz RJ, Babinchak TJ.

Ann Intern Med. 2000 Sep 19;133(6):447-54. Review.PMID: 10975963 [PubMed - indexed for MEDLINE]Related articlesFree article

Changing morbidity of cutaneous diseases in patients with HIV after the introduction of highly active antiretroviral therapy including a protease inhibitor.

Calista D, Morri M, Stagno A, Boschini A.

Am J Clin Dermatol. 2002;3(1):59-62.PMID: 11817969 [PubMed - indexed for MEDLINE]Related articles

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.PMID: 11826235 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Grabar S, Le Moing V, Goujard C, Leport C, Kazatchkine MD, Costagliola D, Weiss L.

Ann Intern Med. 2000 Sep 19;133(6):401-10.PMID: 10975957 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.

Powles T, Imami N, Nelson M, Gazzard BG, Bower M.

AIDS. 2002 Mar 8;16(4):531-6.PMID: 11872995 [PubMed - indexed for MEDLINE]Related articles

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.PMID: 11813503 [PubMed - indexed for MEDLINE]Related articles

Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.

Djomand G, Roels T, Ellerbrock T, Hanson D, Diomande F, Monga B, Maurice C, Nkengasong J, Konan-Koko R, Kadio A, Wiktor S, Lackritz E, Saba J, Chorba T.

AIDS. 2003 Jul;17 Suppl 3:S5-15.PMID: 14565604 [PubMed - indexed for MEDLINE]Related articles

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

Rizzardi GP, Tambussi G, Bart PA, Chapuis AG, Lazzarin A, Pantaleo G.

AIDS. 2000 Oct 20;14(15):2257-63.PMID: 11089613 [PubMed - indexed for MEDLINE]Related articles

Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy.

Agwu A, Lindsey JC, Ferguson K, Zhang H, Spector S, Rudy BJ, Ray SC, Douglas SD, Flynn PM, Persaud D; Pediatric AIDS Clinical Trials Group 381 Study Team.

AIDS Patient Care STDS. 2008 Jul;22(7):545-52.PMID: 18479228 [PubMed - indexed for MEDLINE]Related articles

The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.

Vilchez RA, Finch CJ, Jorgensen JL, Butel JS.

Medicine (Baltimore). 2003 Mar;82(2):77-81.PMID: 12640183 [PubMed - indexed for MEDLINE]Related articles

Comparison of immunologic restoration and virologic response in plasma, tonsillar tissue, and cerebrospinal fluid in HIV-1-infected patients treated with double versus triple antiretroviral therapy in very early stages: The Spanish EARTH-2 Study. Early Anti-Retroviral Therapy Study.

García F, Alonso MM, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, Dalmau D, Ruiz I, Vidal F, Frances A, Segura F, Gomez-Sirvent JL, Cruceta A, Clotet B, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):26-35.PMID: 11064501 [PubMed - indexed for MEDLINE]Related articles

[Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]

Pozio E.

Parassitologia. 2004 Jun;46(1-2):89-93. Review. Italian. PMID: 15305694 [PubMed - indexed for MEDLINE]Related articles

Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.

Rakotoambinina B, Médioni J, Rabian C, Jubault V, Jais JP, Viard JP.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):443-9.PMID: 11511820 [PubMed - indexed for MEDLINE]Related articles

"Discordant" increases in CD4 cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy.

Wood E, Hogg RS, Yip B, Tyndall MW, Sherlock CH, Harrigan RP, O'Shaughnessy MV, Montaner JS.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):159-66.PMID: 12045678 [PubMed - indexed for MEDLINE]Related articles

Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy.

Mezzaroma I, Carlesimo M, Pinter E, Muratori DS, Di Sora F, Chiarotti F, Cunsolo MG, Sacco G, Aiuti F.

Clin Infect Dis. 1999 Dec;29(6):1423-30.PMID: 10585790 [PubMed - indexed for MEDLINE]Related articles

HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.

Sterling TR, Chaisson RE, Moore RD.

AIDS. 2001 Nov 23;15(17):2251-7.PMID: 11698698 [PubMed - indexed for MEDLINE]Related articles

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy.

Shelburne SA, Visnegarwala F, Darcourt J, Graviss EA, Giordano TP, White AC Jr, Hamill RJ.

AIDS. 2005 Mar 4;19(4):399-406.PMID: 15750393 [PubMed - indexed for MEDLINE]Related articles

Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.

Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.

AIDS Res Hum Retroviruses. 2002 Jan 20;18(2):95-102.PMID: 11839142 [PubMed - indexed for MEDLINE]Related articles

Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.

MacArthur RD, Perez G, Walmsley S, Baxter JD, Mullin CM, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) 042/045; Canadian HIV Trials Network (CTN) 102 Protocol Teams.

HIV Clin Trials. 2005 May-Jun;6(3):127-35.PMID: 16192247 [PubMed - indexed for MEDLINE]Related articles

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ.

Clin Infect Dis. 1999 May;28(5):1152-4.PMID: 10452651 [PubMed - indexed for MEDLINE]Related articles